X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with Mic Electronics - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs MIC ELECTRONICS - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

MIC ELECTRONICS 
   Change

Incorporated in 1986, MIC Electronics is a Hyderabad based company whose business revolves mainly around LED (light emitting diode) and LED based products. The company broadly has two segments media, and informatics and communications (ICT). The form... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES MIC ELECTRONICS INDOCO REMEDIES/
MIC ELECTRONICS
 
P/E (TTM) x 37.4 -0.1 - View Chart
P/BV x 2.9 0.1 2,672.9% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 INDOCO REMEDIES   MIC ELECTRONICS
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
MIC ELECTRONICS
Mar-16
INDOCO REMEDIES/
MIC ELECTRONICS
5-Yr Chart
Click to enlarge
High Rs36030 1,221.7%   
Low Rs2498 3,277.6%   
Sales per share (Unadj.) Rs119.08.3 1,438.8%  
Earnings per share (Unadj.) Rs8.4-6.7 -125.3%  
Cash flow per share (Unadj.) Rs15.2-6.2 -244.8%  
Dividends per share (Unadj.) Rs1.600-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs70.713.9 509.1%  
Shares outstanding (eoy) m92.15166.14 55.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.62.2 114.2%   
Avg P/E ratio x36.4-2.8 -1,311.0%  
P/CF ratio (eoy) x20.0-3.0 -671.1%  
Price / Book Value ratio x4.31.3 322.7%  
Dividend payout %19.10-   
Avg Mkt Cap Rs m28,0833,082 911.2%   
No. of employees `0006.0NA-   
Total wages/salary Rs m2,16735 6,262.1%   
Avg. sales/employee Rs Th1,817.0NM-  
Avg. wages/employee Rs Th359.0NM-  
Avg. net profit/employee Rs Th127.7NM-  
INCOME DATA
Net Sales Rs m10,9681,374 798.0%  
Other income Rs m4034 115.4%   
Total revenues Rs m11,0071,409 781.4%   
Gross profit Rs m1,565439 356.6%  
Depreciation Rs m63375 842.6%   
Interest Rs m625 1,321.3%   
Profit before tax Rs m909393 231.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,962 0.0%   
Tax Rs m139-460 -30.2%   
Profit after tax Rs m771-1,109 -69.5%  
Gross profit margin %14.331.9 44.7%  
Effective tax rate %15.3-116.9 -13.0%   
Net profit margin %7.0-80.7 -8.7%  
BALANCE SHEET DATA
Current assets Rs m5,7252,483 230.6%   
Current liabilities Rs m5,4542,368 230.3%   
Net working cap to sales %2.58.3 29.6%  
Current ratio x1.01.0 100.1%  
Inventory Days Days62200 31.1%  
Debtors Days Days72251 28.6%  
Net fixed assets Rs m5,3071,375 386.0%   
Share capital Rs m184332 55.5%   
"Free" reserves Rs m6,3311,364 464.1%   
Net worth Rs m6,5162,307 282.4%   
Long term debt Rs m1,323128 1,030.5%   
Total assets Rs m11,9704,855 246.5%  
Interest coverage x15.684.7 18.5%   
Debt to equity ratio x0.20.1 364.9%  
Sales to assets ratio x0.90.3 323.7%   
Return on assets %7.0-22.7 -30.6%  
Return on equity %11.8-48.1 -24.6%  
Return on capital %12.4-64.2 -19.3%  
Exports to sales %03.3 0.0%   
Imports to sales %012.0 0.0%   
Exports (fob) Rs mNA45 0.0%   
Imports (cif) Rs mNA165 0.0%   
Fx inflow Rs m4,50745 10,015.3%   
Fx outflow Rs m1,141166 685.7%   
Net fx Rs m3,366-121 -2,771.1%   
CASH FLOW
From Operations Rs m886-220 -402.2%  
From Investments Rs m-1,706-7 23,363.0%  
From Financial Activity Rs m1,316231 570.3%  
Net Cashflow Rs m4973 17,124.1%  

Share Holding

Indian Promoters % 59.2 8.0 740.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 91.2 24.6%  
Shareholders   12,805 43,926 29.2%  
Pledged promoter(s) holding % 0.0 54.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   ADANI PORTS & SEZ  KITEX GARMENTS  IIFL HOLDINGS  TIL LTD  BAJAJ FINANCE  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

MIC ELECTRONICS Announces Quarterly Results (1QFY19); Net Profit Down 276.5% (Quarterly Result Update)

Aug 22, 2018 | Updated on Aug 22, 2018

For the quarter ended June 2018, MIC ELECTRONICS has posted a net profit of Rs 49 m (down 276.5% YoY). Sales on the other hand came in at Rs 7 m (down 99.1% YoY). Read on for a complete analysis of MIC ELECTRONICS's quarterly results.

MIC ELECTRONICS Announces Quarterly Results (4QFY18); Net Profit Down 2500.5% (Quarterly Result Update)

Aug 22, 2018 | Updated on Aug 22, 2018

For the quarter ended March 2018, MIC ELECTRONICS has posted a net profit of Rs 2 bn (down 2500.5% YoY). Sales on the other hand came in at Rs 154 m (down 76.7% YoY). Read on for a complete analysis of MIC ELECTRONICS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Sep 21, 2018 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - THOMAS COOK INDIA COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS